Shopping Cart
- Remove All
Your shopping cart is currently empty
Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good therapeutic effect on a variety of tumor cells.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $157 | In Stock | |
| 5 mg | $428 | In Stock | |
| 10 mg | $695 | In Stock | |
| 25 mg | $1,060 | In Stock | |
| 50 mg | $1,430 | In Stock |
| Description | Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good therapeutic effect on a variety of tumor cells. |
| In vitro | Clivatuzumab exhibits high specificity for pancreatic ductal adenocarcinoma (PDAC), showing minimal reactivity towards normal and benign non-tumorous pancreatic tissues. Although it demonstrates limited reactivity (approximately 10% of all samples) towards adenocarcinomas in certain other organs such as the stomach, colon, and lungs [1]. |
| Molecular Weight | 145.42 kDa |
| Cas No. | 1622075-09-5 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.